K-numberK242852
Device nameALM Tube I.D. 6.0, O.D. 8.2 (520843), ALM Tube I.D. 7.0, O.D. 9.7 (520845), ALM Tube I.D. 7.5, O.D. 10.3 (520846), ALM Tube I.D. 8.0, O.D. 11.0 (520847)
ApplicantInomed Medizintechnik GmbH
Product codeETN
Device classClass II
Decision dateJun 13, 2025
DecisionSubstantially Equivalent
Regulation874.1820
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ALM Tube is an endotracheal intubation tube that provides airway ventilation and intraoperative neuromonitoring by recording EMG signals from the laryngeal musculature. It is inserted orally into the trachea during surgery and connects to an external neuromonitoring system to monitor recurrent laryngeal nerve or vagal nerve function.

Technological characteristics

The ALM Tube features 8 electrodes with conductive silver ink on a PVC tube, compared to the predicate device's 2–4 electrodes. Individual electrode areas are slightly larger (~90–99 mm² vs. up to 617 mm²), with comparable cumulative active electrode surface (756 mm² vs. 1456 mm²). Electrode impedance is nearly identical (0.27 kΩ vs. 0.30 kΩ average). Both use ethylene oxide sterilization, dielectric coating insulation, and single-use design; the ALM Tube offers a 1-year shelf life versus the predicate's 3 years and supports up to 12 hours of intubation.

Test standards cited

Biocompatibility: ISO 10993 series (parts 1, 2, 5, 7, 10, 11, 12, 17, 18, 23) and ISO 18562-1. Sterilization: ISO 11135. Packaging and shelf-life: ISO 11607 series. Performance: ISO 5356-1 and ISO 5361. Electrical safety and EMC: device used with IEC 60601-1 and IEC 60601-1-2 compliant neuromonitoring systems.

Substantial equivalence argument

Both devices share identical intended use (airway and EMG monitoring), materials (silver ink electrodes, PVC tube), electrical insulation design, and single-use sterilization method. Although the ALM Tube uses 8 electrodes versus the predicate's 2–4, electrode impedance values are equivalent (0.27 vs. 0.30 kΩ), and comparative impedance testing with neuromonitoring systems demonstrates similar performance. The slightly larger individual electrode areas and greater cumulative surface are not expected to adversely affect performance. Both provide direct and indirect tissue contact in the same anatomical location (oral/tracheal). Testing confirms biocompatibility and performance compliance; human factors evaluation validates usability.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →